血浆β-淀粉样蛋白、总tau蛋白和神经丝轻链水平与卒中风险:一项前瞻性人群研究
在鹿特丹研究中,2002至2005年纳入4661名无卒中参与者,测定血浆Aβ40、Aβ42、总tau和NfL,随访平均10.8±3.3年。基线总tau最高四分位者任何卒中调整HR为1.68(95%CI 1.18-2.40),NfL每增加1个标准差任何卒中HR为1.27(95%CI 1.12-1.44)。Aβ40、Aβ42及Aβ42/40比值与卒中风险无关。
要点
- 基线血浆总tau最高四分位者任何卒中风险较最低四分位升高,调整HR 1.68(95%CI 1.18-2.40)。
- 血浆NfL每增加1个标准差,任何卒中风险升高,HR 1.27(95%CI 1.12-1.44)。
- 血浆Aβ40、Aβ42及Aβ42/40比值与卒中风险无关。
核心结论
- 基线总tau和NfL较高者卒中及多个卒中亚型风险更高,支持神经退行性标志物在卒中病因学中的作用。
研究设计与样本
- 2002至2005年从基于人群的鹿特丹研究纳入4661名无卒中参与者,测定血浆Aβ40、Aβ42、总tau和NfL。
- 采用Cox比例风险模型分析标志物与 incident 卒中的关联,并按卒中亚型及中位年龄、性别、APOE ε4携带状态和教育程度分层。
主要发现
- 平均随访10.8±3.3年,379名参与者发生首次卒中。
- 基线Log2总tau与任何卒中及缺血性卒中风险呈非线性关联:与最低四分位相比,最高四分位总tau的任何卒中调整HR为1.68(95%CI 1.18-2.40)。
- Log2 NfL与任何卒中风险升高相关(每增加1个标准差HR 1.27,95%CI 1.12-1.44),并与缺血性卒中和出血性卒中相关(HR 1.56,95%CI 1.14-2.12)。
- Log2 Aβ40、Aβ42及Aβ42/40比值水平与卒中风险无关。
关键数值与推荐
- 总tau最高四分位 vs 最低四分位:任何卒中调整HR 1.68(95%CI 1.18-2.40)。
- NfL每增加1个标准差:任何卒中HR 1.27(95%CI 1.12-1.44);出血性卒中HR 1.56(95%CI 1.14-2.12)。
- Aβ40、Aβ42及Aβ42/40比值与卒中风险无关联。
临床怎么用
- 本研究提供II级证据:血浆总tau和NfL较高与后续卒中风险升高相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: To unravel whether Alzheimer disease-related pathology or neurodegeneration plays a role in stroke etiology, we determined the effect of plasma levels β-amyloid (Aβ), total-tau, and neurofilament light chain (NfL) on risk of stroke and its subtypes. METHODS: Between 2002 and 2005, we measured plasma Aβ40, Aβ42, total-tau, and NfL in 4,661 stroke-free participants from the population-based Rotterdam Study. We used Cox proportional-hazards models to determine the association between these markers with incident stroke for the entire cohort, per stroke subtype, and by median age, sex, APOE ε4 carriership, and education. RESULTS: After a mean follow-up of 10.8 ± 3.3 years, 379 participants had a first-ever stroke. Log2 total-tau at baseline showed a nonlinear association with risk of any stroke and ischemic stroke: compared to the first (lowest) quartile, the adjusted hazard ratio (HR) for the highest quartile total-tau was 1.68 (95% CI 1.18-2.40) for any stroke. Log2 NfL was associated with an increased risk of any stroke (HR per 1-SD increase 1.27, 95% CI 1.12-1.44), ischemic stroke, and hemorrhagic stroke (HR 1.56, 95% CI 1.14-2.12). Log2 Aβ40, Aβ42, and Aβ42/40 ratio levels were not associated with stroke risk. DISCUSSION: Participants with higher total-tau and NfL at baseline had a higher risk of stroke and several stroke subtypes. These findings support the role of markers of neurodegeneration in the etiology of stroke. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that higher plasma levels of total-tau and NfL are associated with an increased risk of subsequent stroke.
引用
- Heshmatollah A, Fani L, Koudstaal PJ, et al. Plasma β-Amyloid, Total-Tau, and Neurofilament Light Chain Levels and the Risk of Stroke: A Prospective Population-Based Study. Neurology. 2022. PMID: 35232820. doi:10.1212/WNL.0000000000200004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。